Alpha Growth PLC Warrants Exercise and Admission Date (9485A)
June 07 2021 - 01:00AM
UK Regulatory
TIDMALGW
RNS Number : 9485A
Alpha Growth PLC
07 June 2021
Alpha Growth plc
(" Alpha " or the "Company")
Exercise of Warrants and Total Vo ti ng Rights
Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading
financial services specialist in the growing longevity asset class,
announces that further to the announcement on 19 May 2021, the
3,571,429 ordinary shares issued in respect of the exercise of
warrants will be admitted to trading on the main market of the
London Stock Exchange 9 June 2021.
Following the admission, the Company's issued share capital
still comprises 431,887,388 ordinary shares of 0.1p each. There are
no ordinary shares held in treasury. Accordingly, the total number
of vo ti ng rights in Alpha Growth plc following admission will be
431,887,388.
The above figure 431,887,388 may be used by shareholders as the
denominator for the calcula ti ons by which they will determine if
they are required to no ti fy their interest in, or a change to
their interest in, Alpha Growth plc under the FCA's Disclosure
Guidance and Transparency Rules.
** ENDS **
For more information, please visit www.algwplc.com or contact
the following:
Alpha Growth plc +44 (0) 20 3959 8600
Gobind Sahney, Executive Chairman info@algwplc.com
Pello Capital Limited +44 (0) 20 7710 9610
Mark Treharne mt@pellocapital.com
About Alpha Growth plc
Specialist in Longevity Assets
Alpha Growth plc is a financial advisory business providing
specialist consultancy, advisory, and supplementary services to
institutional and qualified investors globally in the multi-billion
dollar market of longevity assets. Building on its well-established
network, the Alpha Growth group has a unique position in the
longevity asset services and investment business, as a listed
entity with global reach. The group's strategy is to expand its
advisory and business services via acquisitions and joint ventures
in the UK and the US to attain commercial scale and provide
holistic solutions to alternative institutional investors who are
in need of specialised skills and unique access to deploy their
financial resource in longevity assets.
Longevity Assets and Non-correlation
As a longevity asset, it is non-correlated to the real estate,
equity capital and commodity markets. Its value is a function of
time because as time passes the value gets closer to the face value
of the policy. Hence creating a steady increase in the net asset
value of the investment. This makes it highly attractive to
investors wishing to counteract volatility within an investment
portfolio and add yield.
Note: The Company only advises on and manages Longevity Assets
that originate in the USA where the structured and life settlement
market is highly regulated.
Important Notice
The content of this announcement has not been approved by an
authorised person within the meaning of the Financial Services and
Markets Act 2000 (FSMA). This announcement has been issued by and
is the sole responsibility of the Company. The information in this
announcement is subject to change.
This announcement is not an offer of securities for sale into
the United States. The securities referred to herein have not been
and will not be registered under the U.S. Securities Act of 1933,
as amended (the Securities Act), and may not be offered or sold,
directly or indirectly, in or into the United States, except
pursuant to an applicable exemption from registration. No public
offering of securities is being made in the United States. This
announcement is not for release, publication or distribution,
directly or indirectly, in or into the United States, Australia,
Canada, the Republic of South Africa, Japan or any jurisdiction
where to do so might constitute a violation of local securities
laws or regulations (a Prohibited Jurisdiction). This announcement
and the information contained herein are not for release,
publication or distribution, directly or indirectly, to persons in
a Prohibited Jurisdiction unless permitted pursuant to an exemption
under the relevant local law or regulation in any such
jurisdiction.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
FURDKQBPFBKDAAK
(END) Dow Jones Newswires
June 07, 2021 02:00 ET (06:00 GMT)
Alpha Growth (LSE:ALGW)
Historical Stock Chart
From Feb 2024 to Mar 2024
Alpha Growth (LSE:ALGW)
Historical Stock Chart
From Mar 2023 to Mar 2024